샘플 요청 목록

 카트 문의
시장보고서
상품코드
1792792

분자 운송 배지 시장

Molecular Transport Medium
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 481 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

분자 운송 배지 세계 시장은 2030년까지 17억 달러에 달할 전망

2024년에 16억 달러로 추정되는 분자 운송 배지 세계 시장은 2024년부터 2030년까지 CAGR 0.8%로 성장하여 2030년에는 17억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 활성 운송 배지는 CAGR 0.9%를 기록하며 분석 기간 종료까지 11억 달러에 달할 것으로 예상됩니다. 불활성화 운송 배지 부문의 성장률은 분석 기간 동안 CAGR 0.4%로 추정됩니다.

미국 시장은 4억 3,830만 달러로 추정, 중국은 CAGR 1.6%로 성장 예측

미국의 분자 운송 배지 시장은 2024년에 4억 3,830만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 2억 9,760만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 1.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 0.2%와 0.6%로 예측됩니다. 유럽에서는 독일이 CAGR 약 0.3%로 성장할 것으로 예측됩니다.

세계의 분자 운송 배지 시장 - 주요 동향과 촉진요인 정리

분자 운송 배지가 진단 정확도에 필수적인 이유는 무엇인가?

분자 운송 배지(MTM)는 분자 검사를 위해 채취한 임상 시료의 핵산 무결성을 유지하는 데 중요한 역할을 하며, 특히 운송 및 보관 중에 중요한 역할을 합니다. MTM은 바이러스 RNA와 DNA를 안정화시키면서 병원체를 비활성화하도록 설계되어 PCR, RT-PCR, 차세대 시퀀싱 등의 다운스트림 애플리케이션에 필수적입니다. 그 중요성은 특히 COVID-19 팬데믹 기간 동안 분자 검사가 광범위하게 이루어지고 신뢰할 수 있는 시료 보존이 대규모로 요구되는 상황에서 더욱 강조되었습니다.

기존의 바이러스 운송 배지와 달리 MTM은 콜드체인 물류가 없는 경우에도 핵산이 분해되지 않도록 보장합니다. 따라서 현장 수집 시나리오나 자원이 부족한 환경에서 특히 유용하게 사용할 수 있습니다. MTM은 호흡기 바이러스뿐만 아니라 감염 진단, 종양학, 유전자 스크리닝, 법의학에서 다양한 병원체에도 사용되고 있습니다. 분자진단이 맞춤형 의료와 질병 감시의 중심이 되고 있는 현재, 시료 운송 배지의 신뢰성은 그 어느 때보다 중요해지고 있습니다.

제품의 특징과 구성은 어떻게 최적화되어 있는가?

최신 MTM은 접촉 시 바이러스를 불활성화하도록 처방되어 있어 취급 및 처리 시 생물학적 안전성이 보장됩니다. 일반적으로 핵산 안정제, 단백질 변성제, 미생물의 증식을 방지하는 약제를 포함한 완충액을 포함합니다. 현재는 표백제와 혼합 시 위험을 최소화하기 위해 구아니디늄 화합물을 포함하지 않는 제품이 많으며, 일부는 수동 및 자동 추출 워크플로우 모두에 대응하는 제품도 있습니다.

넓은 온도 범위에서의 안정성은 우선적으로 중요한 특징이며, 샘플을 냉장 보관하지 않고도 며칠 동안 생존할 수 있습니다. 일부 MTM은 현재 면봉과 타액 샘플 모두에 사용할 수 있는 것으로 확인되어 채취 프로토콜에 유연성을 제공하고 있습니다. 즉시 사용 가능한 포맷, 색상으로 구분된 캡, 사전 라벨링된 튜브, 바코드 호환성을 통해 고처리량 검사 환경에서 사용 편의성과 시료의 추적성을 향상시킵니다. 로봇 시스템 및 하이스루풋 실험실 분석 장비와의 호환성 또한 요구사항이 증가하고 있습니다.

수요가 확대되고 있는 지역과 주요 사용자는?

분자 운송 배지에 대한 수요는 진단 실험실, 병원, 연구 센터, 공중 보건 기관에서 증가하고 있습니다. 분자 검사는 감염 대책, 종양 진단, 산전 검사 등 안전하고 신뢰할 수 있는 시료 취급이 필요한 분야에서 널리 채택되고 있습니다. 정부와 보건기관은 질병 발생 및 집단 검사 프로그램에 대비하기 위해 MTM을 비축하고 있습니다.

일상적인 임상 사용 외에도 MTM은 바이오뱅크, 역학 연구, 재택 검사 키트에도 필수적입니다. 제약 업계에서도 정확한 핵산 분석이 요구되는 임상시험에서 MTM을 사용하고 있습니다. 병원체 감시, 환경 샘플링, 유전체 연구 등을 수행하는 학술 연구기관에서는 RNA와 DNA의 프로파일을 저장하고 추후 분석에 활용하기 위해 MTM을 활용하고 있습니다. Point-of-Care 및 분산형 검사가 확대됨에 따라, 작고 사용하기 쉽고 안정적인 운송 배지에 대한 수요가 지속적으로 증가하고 있습니다.

분자 운송 배지 시장의 성장을 촉진하는 요인은 무엇인가?

분자 운송 배지 시장의 성장은 분자진단의 채택 확대, 정확하고 안전한 시료 취급에 대한 수요 증가, 감염병 감시 프로그램 확대 등 여러 요인에 의해 주도되고 있습니다. 진단 검사가 RNA 및 DNA 기반 검사로 전환됨에 따라, 샘플의 열화 및 오염을 방지하는 샘플 보존 솔루션의 필요성이 대두되고 있습니다.

전염병과 신흥 병원체는 신뢰할 수 있는 시료 운송 시스템의 중요성을 강조하며, 정부와 민간 연구소 모두 MTM 인프라에 대한 투자를 촉진하고 있습니다. 유통기한, 생물안전 규정 준수, 콜드체인 독립성 향상으로 인해 다양한 지역에서 MTM이 더욱 실용화되고 있습니다. 재택 진단과 분산형 검사 플랫폼의 성장도 수요에 기여하고 있습니다. 이러한 추세는 전 세계 헬스케어 시스템 전반에 걸쳐 신속하고 안전하며 확장 가능한 분자 검사를 지원하는 시장을 형성하고 있습니다.

부문

제품 유형(활성 운송 배지, 불활성화 운송 배지), 샘플(비강 세정·면봉 샘플, 객담 샘플, 타액 샘플, 분변·변 샘플, 소변 샘플, 혈액 샘플, 기타 샘플), 용도(바이러스 용도, 세균 용도, 비정형 세균 용도, 마이코박테리아·진균 감염 용도), 최종 용도(진단 실험실 최종 용도, 미생물 실험실 최종 용도, 병원·진료소 최종 용도, 기타 최종 용도)

조사 대상 기업 사례

  • 2B Scientific Limited
  • Ab Medical
  • AccuGene USA
  • Becton, Dickinson and Company(BD)
  • BioBoaVista
  • BioMed Diagnostics, Inc.
  • COPAN Diagnostics Inc.
  • Creative Life Sciences Co. Ltd.
  • DiaSorin Molecular LLC
  • EKF Diagnostics Holdings plc
  • Hardy Diagnostics
  • HiMedia Laboratories Pvt. Ltd.
  • Longhorn Vaccines and Diagnostics LLC
  • Medical Wire & Equipment(MWE)
  • Mylab Discovery Solutions Pvt. Ltd.
  • Puritan Medical Products Company, LLC
  • Quidel Corporation
  • Starplex Scientific Inc.
  • Thermo Fisher Scientific Inc.
  • Titan Biotech Ltd.
  • Trinity Biotech plc

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.25

Global Molecular Transport Medium Market to Reach US$1.7 Billion by 2030

The global market for Molecular Transport Medium estimated at US$1.6 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 0.8% over the analysis period 2024-2030. Active Transport Medium, one of the segments analyzed in the report, is expected to record a 0.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Inactivated Transport Medium segment is estimated at 0.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$438.3 Million While China is Forecast to Grow at 1.6% CAGR

The Molecular Transport Medium market in the U.S. is estimated at US$438.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$297.6 Million by the year 2030 trailing a CAGR of 1.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.2% and 0.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.3% CAGR.

Global Molecular Transport Medium Market - Key Trends & Drivers Summarized

Why Is Molecular Transport Medium Crucial for Diagnostic Accuracy?

Molecular transport medium (MTM) plays a critical role in preserving the integrity of nucleic acids in clinical samples collected for molecular testing, especially during transport and storage. It is designed to inactivate pathogens while stabilizing viral RNA or DNA, making it essential for downstream applications such as PCR, RT-PCR, and next-generation sequencing. Its importance was particularly underscored during the COVID-19 pandemic, where widespread molecular testing demanded reliable sample preservation at scale.

Unlike traditional viral transport mediums, MTM ensures that nucleic acids remain undegraded, even in the absence of cold chain logistics. This makes it especially useful in field collection scenarios and low-resource settings. MTM is used not only for respiratory viruses but also for a range of pathogens in infectious disease diagnostics, oncology, genetic screening, and forensic science. With molecular diagnostics becoming central to personalized medicine and disease surveillance, the reliability of sample transport mediums has become more critical than ever.

How Are Product Features and Composition Being Optimized?

Modern MTMs are formulated to inactivate viruses upon contact, ensuring biosafety during handling and processing. They typically include a buffered solution with nucleic acid stabilizers, protein denaturants, and agents that prevent microbial growth. Many are now free of guanidinium compounds to minimize risks when mixed with bleach, and several variants are compatible with both manual and automated extraction workflows.

Stability over a wide range of temperatures is a key feature being prioritized, allowing samples to remain viable for several days without refrigeration. Some MTMs are now validated for use with both swab and saliva samples, offering flexibility in collection protocols. Ready-to-use formats, color-coded caps, pre-labeled tubes, and barcoding compatibility are enhancing usability and sample traceability in high-throughput testing environments. Compatibility with robotic systems and high-throughput laboratory analyzers is also a growing requirement.

Where Is Demand Expanding and Who Are the Main Users?

Demand for molecular transport medium is rising in diagnostic laboratories, hospitals, research centers, and public health institutions. Molecular testing is being adopted widely across infectious disease control, oncology diagnostics, and prenatal screening, all of which require secure and reliable sample handling. Governments and health agencies are stockpiling MTMs to ensure readiness for disease outbreaks and mass testing programs.

In addition to routine clinical use, MTMs are integral to biobanking, epidemiological studies, and home-based testing kits. The pharmaceutical industry also uses MTMs in clinical trials where accurate nucleic acid analysis is required. Academic research institutions conducting pathogen surveillance, environmental sampling, or genomic research depend on MTMs to preserve RNA and DNA profiles for later analysis. As point-of-care and decentralized testing expand, demand for compact, easy-to-use, and stable transport media continues to grow.

What Factors Are Driving Growth In The Molecular Transport Medium Market?

Growth in the molecular transport medium market is driven by several factors including increased adoption of molecular diagnostics, rising demand for accurate and safe sample handling, and expansion of infectious disease surveillance programs. As diagnostic testing shifts toward RNA and DNA-based methods, the need for sample preservation solutions that prevent degradation and contamination is becoming more pronounced.

Epidemics and emerging pathogens have highlighted the importance of reliable specimen transport systems, prompting investment in MTM infrastructure by both governments and private labs. Improvements in shelf life, biosafety compliance, and cold chain independence are making MTMs more practical across varied geographies. Growth in home diagnostics and decentralized testing platforms is also contributing to demand. Together, these trends are shaping a market that supports rapid, secure, and scalable molecular testing across global healthcare systems.

SCOPE OF STUDY:

The report analyzes the Molecular Transport Medium market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Active Transport Medium, Inactivated Transport Medium); Sample (Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample, Other Samples); Application (Virus Application, Bacteria Application, Atypical Bacteria Application, Mycobacterial & Fungal Infection Application); End-Use (Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • 2B Scientific Limited
  • Ab Medical
  • AccuGene USA
  • Becton, Dickinson and Company (BD)
  • BioBoaVista
  • BioMed Diagnostics, Inc.
  • COPAN Diagnostics Inc.
  • Creative Life Sciences Co. Ltd.
  • DiaSorin Molecular LLC
  • EKF Diagnostics Holdings plc
  • Hardy Diagnostics
  • HiMedia Laboratories Pvt. Ltd.
  • Longhorn Vaccines and Diagnostics LLC
  • Medical Wire & Equipment (MWE)
  • Mylab Discovery Solutions Pvt. Ltd.
  • Puritan Medical Products Company, LLC
  • Quidel Corporation
  • Starplex Scientific Inc.
  • Thermo Fisher Scientific Inc.
  • Titan Biotech Ltd.
  • Trinity Biotech plc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Molecular Transport Medium - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate Molecular Diagnostics Propels Adoption of Molecular Transport Media
    • Expansion of Infectious Disease Testing Drives Market Utilization
    • Growth in PCR, RT-PCR, and NGS-Based Diagnostics Strengthens Business Case for Stabilized Transport Solutions
    • Need for High Sample Integrity and Nucleic Acid Preservation Spurs Use of Specialized Transport Media
    • Increase in Point-of-Care and At-Home Testing Kits Expands Demand for Pre-Filled, Ready-to-Use Transport Tubes
    • Technological Advancements in Viral and Bacterial RNA/DNA Stabilization Enhance Product Efficacy
    • Integration of Antimicrobial Agents and Inactivating Components Improves Biosafety and Laboratory Handling
    • Growth in Public Health Surveillance Programs Throws Spotlight on Reliable Transport Media Infrastructure
    • Expansion of Molecular Testing Labs in Emerging Markets Strengthens Demand for Cost-Effective Media
    • Surge in Clinical Trials and Biobanking Applications Creates Consistent Demand for High-Fidelity Sample Transport
    • Increasing Incidence of Antimicrobial Resistance Drives Microbiome Studies Supported by Molecular Media
    • Growth in Veterinary and Zoonotic Disease Surveillance Broadens Application of Transport Medium
    • Rising Investments in Pandemic Preparedness Initiatives Reinforce Strategic Stockpiling of Transport Media
    • Integration of Cold Chain-Free and Ambient Temperature-Stable Media Expands Use in Remote Testing Sites
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Molecular Transport Medium Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Molecular Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Active Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Active Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Active Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inactivated Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Inactivated Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Inactivated Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Virus Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Virus Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Virus Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Bacteria Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Atypical Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Atypical Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Atypical Bacteria Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Mycobacterial & Fungal Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Mycobacterial & Fungal Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Mycobacterial & Fungal Infection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Microbiology Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Microbiology Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Microbiology Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Nasal Washes & Swabs Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Nasal Washes & Swabs Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Nasal Washes & Swabs Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Sputum Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Sputum Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Sputum Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Saliva Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Saliva Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Saliva Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Fecal & Stool Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Fecal & Stool Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Fecal & Stool Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Urine Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Urine Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Urine Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Blood Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Blood Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Blood Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • JAPAN
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • CHINA
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: China 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: China 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: China 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • EUROPE
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Molecular Transport Medium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • FRANCE
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 119: France Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: France 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: France 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: France 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: France 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • GERMANY
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Germany 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Germany 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Italy 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Italy 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 155: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: UK 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: UK 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Spain 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Spain 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Spain 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Spain 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Russia 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Russia 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Russia 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Russia 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Molecular Transport Medium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Australia 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Australia 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Australia 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Australia 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • INDIA
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 230: India Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: India 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: India 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 236: India Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: India 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 239: India Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: India 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: South Korea 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: South Korea 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: South Korea 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: South Korea 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Molecular Transport Medium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Latin America 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Latin America 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Latin America 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Argentina 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Argentina 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Argentina 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Argentina 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Brazil 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Brazil 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Brazil 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Brazil 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Mexico 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Mexico 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Mexico 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Mexico 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Molecular Transport Medium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 331: Middle East 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 334: Middle East 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 340: Middle East 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 346: Iran 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 349: Iran 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 352: Iran 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 355: Iran 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 358: Israel 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 361: Israel 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 364: Israel 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 367: Israel 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 382: UAE 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 385: UAE 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 388: UAE 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 391: UAE 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
  • AFRICA
    • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 406: Africa 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 409: Africa 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 412: Africa 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 415: Africa 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제